Psyence Biomedical Ltd.
PBM
$3.92
$0.246.52%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 890.50K | 832.90K | 565.40K | 557.00K | 184.70K |
| Depreciation & Amortization | 1.00K | 900.00 | 100.00 | 100.00 | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.16M | 966.60K | 650.60K | 632.20K | 176.20K |
| Operating Income | -1.16M | -966.60K | -650.60K | -632.20K | -176.20K |
| Income Before Tax | 141.50K | 1.48M | -24.78M | -24.76M | -309.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 141.50K | 1.48M | -24.78M | -24.76M | -309.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 141.50K | 1.48M | -24.78M | -24.76M | -309.70K |
| EBIT | -1.16M | -966.60K | -650.60K | -632.20K | -176.20K |
| EBITDA | -1.16M | -965.70K | -650.60K | -632.10K | -- |
| EPS Basic | 4.07 | 51.14 | -1.11K | -1.11K | -13.82 |
| Normalized Basic EPS | -26.00 | -15.94 | -8.93 | -8.37 | -8.64 |
| EPS Diluted | 4.06 | 51.13 | -1.11K | -1.11K | -13.82 |
| Normalized Diluted EPS | -25.99 | -15.94 | -8.93 | -8.37 | -8.64 |
| Average Basic Shares Outstanding | 34.70K | 28.90K | 22.40K | 22.40K | 22.40K |
| Average Diluted Shares Outstanding | 34.70K | 29.00K | 22.40K | 22.40K | 22.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |